Background: Sex-race stratification may lead to identification of risk factors for low antihypertensive medication adherence that are not apparent when assessing risk factors in women and men without race stratification. We examined risk factors associated with low pharmacy refill adherence across sex-race subgroups (white women, black women, white men, black men) within the Cohort Study of Medication Adherence among Older Adults (n = 2,122).
INTRODUCTION
H ypertension is a leading cause of mortality and disease burden, and a major public health and clinical challenge affecting older adults. [1] [2] [3] Despite advances in hypertension management and treatment, almost 30% of adults taking antihypertensive medication have uncontrolled blood pressure. 1, 4 Low adherence to antihypertensive medication is associated with poor blood pressure control in older adults, 5 and higher rates of emergency room visits, hospitalizations, cardiovascular events, and mortality. [6] [7] [8] Understanding risk factors for low antihypertensive medication adherence may support development of personalized interventions to promote adherence and improve blood pressure control among older adults.
Sex and race differences in the prevalence of hypertension, blood pressure control, and antihypertensive medication adherence are well documented.
1,5,9,10 A higher prevalence of hypertension and uncontrolled blood pressure has been reported among older women compared to older men, and among blacks compared to whites. 1, 2, 11, 12 Race differences in antihypertensive medication adherence mirror those for blood pressure control-antihypertensive medication adherence and blood pressure control are lower among blacks compared to whites. 13 Studies reporting sex differences in pharmacy refill adherence among men and women are less consistent: some studies report similar prevalence of low pharmacy refill adherence in older men and women, 5, 14 while others report higher prevalence of low pharmacy refill adherence among older women compared to men. 10 Furthermore, sex and race differences research has helped to uncover risk factors for low antihypertensive medication adherence that are sex-or race-specific. For example, Holt et al. found that reduced sexual functioning and high body mass index were associated with low self-report antihypertensive medication adherence among older, hypertensive men but not women. 9 In this case, sex stratification uncovered sex-specific risk factors for low antihypertensive medication adherence that would not have otherwise been identified using a nonstratified approach.
The recent mandate from the National Institutes of Health 15 to include, where appropriate, assessment of sex differences together with the current era of personalized and precision medicine are powering efforts to examine sex and race differences. While growing recognition of the importance of sex and race differences in research and increasing number of sex-stratified and race-stratified assessments are promising, stratification by sex and race (e.g., white women, black women, white men, black men) may be necessary to identify risk factors for antihypertensive medication adherence that would not be identified in a sex-or race-stratified analysis alone. However, few studies have comprehensive risk factor data from a predominantly black and white patient population linked to patient-level pharmacy fill data and self-reported race to evaluate patterns across sex-race subgroups.
The Cohort Study of Medication Adherence among Older Adults (CoSMO) includes data from a comprehensive patient adherence risk factor survey linked to pharmacy fill and medical claims, and medical records in over 2,000 community-dwelling older black and white women and men with treated hypertension. 5 We examined socio-demographic, clinical, psychosocial, behavioral, and healthcare factors 5, 16 associated with low pharmacy refill adherence in women, men, and across 4 sex-race subgroups of CoSMO participants: white women, black women, white men, and black men. Sex-race stratification may lead to identification of risk factors that are not apparent when assessing risk factors in women and men without race stratification, which, in turn, may guide development and implementation of tailored interventions to increase antihypertensive medication adherence and blood pressure control among older patients.
METHODS

Study Population, Study Design, and Data Collection
We conducted a cross-sectional analysis of baseline data from CoSMO. The CoSMO study design, participant baseline characteristics, and response rates have been previously described. 5 In brief, CoSMO enrolled 2,194 adults aged 65 years or older with essential hypertension from a large managed care organization in southeastern Louisiana. Recruitment and completion of baseline telephone interviews by participants occurred from August 21, 2006 to September 30, 2007 . CoSMO was approved by Ochsner Clinic Foundation Institutional Review Board, and the privacy board of the managed care organization; participants provided verbal consent to participate in this minimal risk study. This analysis included 2,122 individuals with pharmacy fill data for antihypertensive medication at baseline and reported black or white race. Data from a patient risk factor survey and pharmacy utilization and medical claims databases of the managed care organization were analyzed. 
Outcome: Pharmacy Refill Medication Adherence
Pharmacy refill adherence was calculated as proportion of days covered (PDC) using all antihypertensive prescriptions filled in the year prior to the baseline risk factor survey. PDC was calculated as the number of days with medication available divided by the number of days between the first and last pharmacy fills in the 1-year period. A PDC for each antihypertensive medication class was calculated for each participant and an overall PDC was calculated as the average across all antihypertensive medication classes. Low adherence was defined as PDC less than 0.80. 7 
Risk Factors for Low Antihypertensive Medication Adherence
Using a conceptual model as a guide, 8 risk factors were assessed using a telephone-administered comprehensive participant risk factor survey. 5 
Socio-Demographic and Clinical Risk Factors
Socio-demographic and clinical characteristics included sex, race, age, marital status, educational attainment, hypertension duration, weight, and height. BMI was calculated as weight (kg)/height (m 2 ). Hypertension knowledge was assessed using a validated tool 17 ; participants with scores in the lowest tertile were categorized as having low hypertension knowledge. 18 Comorbidities were identified from claims data and used to calculate the Charlson comorbidity index score, which was dichotomized as <2 vs. 2.
19, 20 The number of classes of antihypertensive medications filled in the year prior to the baseline survey was obtained from a pharmacy utilization database and categorized as <3 classes vs. 3 classes.
Healthcare System Risk Factors
Participant satisfaction was assessed using 3 domains from the Group Health Association of America Consumer Satisfaction Survey: overall satisfaction, access to care, and communication. 21 Mean scores corresponding to a poor and fair rating were classified as not satisfied. Reducing antihypertensive medication due to cost was ascertained by asking participants if they had taken less high blood pressure medication than was prescribed because of the cost (yes vs. no); and participant-reported number of visits to a primary care provider in the year prior to the baseline survey was categorized as <6 visits vs. 6 visits. 5 
Psychosocial and Behavioral Risk Factors
Lifestyle behaviors included smoking status and weekly intake of alcoholic beverages. 5 Presence of depressive symptoms was defined as a score 16 using the 20-item Center for Epidemiologic Studies Depression Scale. 22 Low social support was defined as scores in the lowest tertile utilizing the RAND medical outcomes study social support survey, 23 and low coping was defined as scores below the median utilizing the shortened version of the John Henry Active Coping scale. 24 Perceived high stress was defined as a score in the highest tertile utilizing the Perceived Stress Scale. 25 
Self-Management Risk Factors
Self-management behaviors 5 included the use of complementary and alternative medicines at least several times or on a regular basis in the year prior to the baseline interview (CAM; dichotomized as yes or no) 26 and the use of lifestyle modifications (i.e., salt reduction, fruit and vegetable consumption, exercise, and weight management) to lower blood pressure. 27 The total number of lifestyle modifications was summed for each participant and dichotomized as <2 or 2.
5
Statistical Analysis
Participant characteristics and prevalence of low antihypertensive medication adherence were calculated overall and within each sex-race subgroup. Within each sex, chi-square tests were used to determine the statistical significance of differences in participant characteristics by race. Bivariate associations of participant characteristics with low PDC adherence were assessed within sex and sex-race subgroups. Sex-and sex-racestratified multivariable Poisson regression models with robust standard errors were used to estimate the adjusted prevalence ratios and 95% confidence intervals for associations between participant characteristics and low adherence. All variables were included simultaneously in the multivariable models, with the exception of stress (due to its collinearity with depressive symptoms) and the healthcare satisfaction domains related to communication and healthcare access (due to their collinearity with overall healthcare satisfaction). We tested for effect modification by race by including multiplicative interaction terms for each main effect (e.g., race * cost) in separate sex-stratified multivariable models. Interaction was tested at the alpha = 0.05 level of significance. Analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC) and Stata version 14.1 (StataCorp, College Station, TX). The figure was created using R 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Of the 2,122 participants, 48.9% were 75 years old or older, 59.2% were women (37.3% white women, 21.9% black women), and 40.8% were men (31.9% white men and 8.9% black men). Overall, 29.1% of the study population had low antihypertensive medication adherence (Table 1 ). The prevalence of low adherence differed between whites and blacks (24.4% and 39.7%, respectively, P < 0.001), but not between men and women (28.6% and 29.5%, respectively, P = 0.682).
Black women were more likely to have low adherence compared to white women (Table 1; 40.7% and 22.9%, respectively, P < 0.001). Compared to black women, white women were older and were more likely to have had hypertension for less than 10 years, to be taking fewer than 3 classes of antihypertensive medications, and to consume 2 or more alcoholic beverages/week. Also, white women were less likely to be unmarried, have less than a high school education, have low hypertension knowledge, have 2 or more comorbidities, have a high BMI, indicate that they were not satisfied with their healthcare, reduce antihypertensive medications due to cost, have low social support, have high stress and report 2 or more lifestyle modifications for blood pressure management than black women.
The prevalence of low antihypertensive medication adherence associated with participant characteristics, among women overall and for white women and black women, separately, is presented in Table 2 . In the multivariable-adjusted model for all women (Table 3) , hypertension duration less than 10 years, having a comorbidity score 2, taking fewer than 3 classes of antihypertensive medications, reducing medications due to cost, depressive symptoms, and being black were associated with low adherence. Among white women, reporting hypertension duration less than 10 years (PR = 1.40; 95% CI: 1.06, 1.83; P = 0.016), having a comorbidity score 2 (prevalence ratio [PR] = 1.49; 95% CI: 1.13, 1.97; P = 0.004), and reducing medications due to cost (PR = 2.31; 95% CI: 1.58, 3.39; P < 0.001) were associated with low adherence (Table 3) . For black women, only reducing antihypertensive medications due to cost (PR = 2.10; 95% CI: 1.62, 2.73; P < 0.001) was associated with low adherence (Table 3 ). Among women, there was no effect modification by race for any participant characteristic (P-values for all interactions > 0.05).
The prevalence of low antihypertensive medication adherence was higher among black men than white men Table 1 . Characteristics of CoSMO study participants, overall and in sex-race subgroups.
Women Men
Overall (n = 2,122) n (%) Compared to black men, white men were more likely to be 75 years or older, be taking fewer than 3 classes of antihypertensive medication, and consume 2 or more alcoholic beverages/week. White men were less likely than black men to have less than a high school education, have low hypertension knowledge, reduce medications due to cost, report depressive symptoms, and engage in 2 or more lifestyle modifications for blood pressure control. The prevalence of low antihypertensive medication adherence associated with participant characteristics, among men overall and for white men and black men, separately, is presented in Table 4 . In the multivariableadjusted model for men overall (Table 5) , reducing medications due to cost was associated with low adherence. In the sex-race subgroup models, not being married (PR = 1.36; 95% CI: 1.00, 1.85; P = .047), reducing antihypertensive medication due to cost (PR = 2.23; 95% CI: 1.44, 3.44; P < .001), and experiencing depressive symptoms (PR = 1.63; 95% CI: 1.14, 2.34; P = .007) were associated with low adherence among white men. In black men, reducing antihypertensive medications due to cost (PR = 1.68; 95% CI: 1.05, 2.67; P = .030), reporting 6 or more primary care visits in the last year (PR = 1.54; 95% CI: 1.04, 2.28; P = 0.032), and complementary and alternative medicine use (PR = 1.73; 95% CI: 1.15, 2.60; P = 0.009) were associated with low adherence. Among men, not being married and having depressive symptoms had a different effect on low adherence among white men compared to black (P-values for the interactions were 0.038 and 0.004, respectively; Figure 1 ).
DISCUSSION
In this study, we identified socio-demographic, clinical, psychosocial, behavioral, self-management, and healthcare system risk factors associated with low pharmacy refill medication adherence in adults with essential hypertension by sex and within sex-race subgroups. The prevalence of low antihypertensive medication adherence was higher among blacks vs. whites, overall and when stratified by sex. No sex differences in the prevalence of low adherence were identified. While reducing medications due to cost was associated with low antihypertensive medication adherence across sex-stratified and sex-race-stratified analyses, other risk factors were identified only after sex-race stratification. Furthermore, statistically significant interactions by race among older men revealed important distinctions in black and white men regarding the association between low adherence and not being married, and between low adherence and having depressive symptoms. This study extends prior research by evaluating a comprehensive set of risk factors linked to an objective measure of medication adherence in women and men and stratifying by 4 sex-race groups. These results may provide insight into sex-race-specific risk factors for low antihypertensive medication adherence in older women and men and lead to development of personalized strategies to address low adherence and improve blood pressure control in older patients.
Risk Factors Associated With Low Pharmacy Refill Adherence Across Sex-Stratified and Sex-Race Subgroup Analyses
Consistent with previous studies, 28, 29 reducing medications due to cost, a modifiable risk factor, was associated with low PDC adherence in both men and women, and across sex-race subgroups. While the overall percentage of participants who reported reducing their medications due to cost was low (only 3.6% of participants), the association was strong, signaling that targeted medication cost reduction interventions could produce substantial benefits for a subset of patients for whom cost is a barrier. Cost-related underuse of medications for older adults with chronic disease is associated with healthcare coverage factors (increasing out of pocket costs and inadequate prescription coverage) as well as the quality of the physicianÀpatient relationship. 29, 30 A survey of medicare beneficiaries found that 39% of seniors who reported cost-related nonadherence had not talked with their physicians about this barrier. 30 While deficiencies in healthcare coverage for medications are amenable to changes at the policy level, there may also be opportunities for healthcare providers to address cost-related nonadherence by addressing this barrier during clinic visits and prescribing lower cost (e.g., generic) medications as appropriate.
In our study, blacks reported higher prevalence of cost-related nonadherence than whites. Similarly, Gellad et al found that issues related to medication affordability were more prevalent among blacks than whites 31 and in a focus group study, Holt et al found that black participants elaborated on cost issues more than white participants. 32 Thus, special attention to medication cost barriers among black patients may be warranted.
Risk Factors Associated With Low Pharmacy Refill Adherence for Women
Among all women, having shorter duration of hypertension, having more comorbidities, taking fewer classes of antihypertensive medications, and reporting depressive symptoms were associated with low antihypertensive medication adherence. These results are consistent with previous reports. 6, [33] [34] [35] [36] Furthermore, sex-race stratification revealed that the associations between comorbidities and low antihypertensive medication adherence, and shorter Table 5 . Multivariable-adjusted prevalence ratios for low antihypertensive pharmacy refill medication adherence among CoSMO men, overall and for black and white men separately.
All men (n = 850) PR (95% CI)
White men (n = 666) PR (95% CI)
Black men (n = 184) PR (95% CI) y P-value for not married-by-race interaction in overall model = 0.038. z P-value for depressive symptoms-by-race interaction in overall model = 0.004.
hypertension duration and antihypertensive medication adherence found among all women were driven primarily by white women. While neither number of comorbidities nor duration of hypertension is "modifiable" in the context of a healthcare encounter, considering these risk factors may help providers to identify patients at risk for low antihypertensive medication adherence. The associations between taking 3 or more classes of antihypertensive medications and low medication adherence, and reporting depressive symptoms and low adherence that were detected among all women were no longer significant when the analysis was stratified by sex-race. Because the magnitude of these effects were similar for white women and black women, sex-race stratification decreased the sample size and thus reduced the statistical power to detect a difference in prevalence of low adherence between those with and without these risk factors. In the case of depressive symptoms, for example, the prevalence ratios for white women and black women were nearly identical to the prevalence ratio for all women, but the decreased sample size produced larger confidence intervals spanning 1. Thus, for women, evaluating both sex-and sex-race stratification revealed important information about risk factors for low antihypertensive medication adherence.
Risk Factors Associated With Low Pharmacy Refill Adherence for Men
While only reduction in medications due to cost was associated with low medication adherence in the overall model for men, further stratification by race revealed risk factors unique to white or black men. Depressive symptoms were associated with low adherence among white men; however, this risk factor had a nonsignificant protective effect for black men (P-value for interaction = 0.004). While previous research documented an overall association between depression and nonadherence in nonstratified analyses, 37, 38 and an association between depression and nonadherence among women in sex-stratified analyses, 9 our finding may provide new insights on sex-race differences. It is possible that aggregating white and black men in a single model obscures an association between depressive symptoms and low antihypertensive medication adherence for white men. Further research is needed to explain this race difference, and to demonstrate whether interventions to address depressive symptoms can improve antihypertensive medication adherence and blood pressure control among older men with comorbid depression and hypertension.
Race also modified the effect of marriage on low antihypertensive medication adherence among men. Specifically, not being married was associated with low medication adherence among white men only (P-value for interaction term = 0.038). The finding for white men is consistent with studies that have reported marriage or spousal support as a protective factor for low medication adherence, poor cardiovascular outcomes, and increased mortality among elderly men. 39, 40 Having a spouse may discourage unhealthy lifestyle behaviors, such as alcohol consumption, smoking, or substance abuse, or may provide practical FIGURE 1. Prevalence ratios for low antihypertensive medication adherence among white and black men for depressive symptoms and marital status.
Model adjusted for age, education, hypertension knowledge, hypertension duration, comorbidities, body mass index, number of classes by antihypertensive medications, healthcare satisfaction, reduction in medications due to cost, number of visits to primary physician in past year, smoking status, alcohol use, social support, coping, complementary and alternative medicine use, and adoption of healthy lifestyle modifications. support for remembering doctor appointments, pharmacy visits, previous medical history, and assisting with maintaining medication adherence. 39, 41 While marital status is not modifiable in the context of a medical encounter, it may serve to flag hypertensive patients at risk for low adherence. We were unable to assess the impact of marital quality on low adherence in black or white men. Recent studies have identified marital quality as a determinant of cardiovascular health outcomes, antihypertensive medication adherence and blood pressure control, 42 with some health benefits of high relationship quality unique to blacks. 43 Future research is needed regarding marital quality and its influence on health behaviors and antihypertensive medication adherence in men with hypertension.
The current study also found a statistically significant association between having 6 or more visits to a primary physician in the prior year and low antihypertensive medication adherence only among black men. It is possible that those with lower adherence have poorly controlled disease and worse health, requiring them to visit a physician more often. 44 Further research is needed to understand this race difference.
The association between CAM use and low antihypertensive medication adherence, which was specific to black men, is consistent with previous research related to race differences in the use of CAM. Previous studies have reported high prevalence of CAM use among blacks, 45, 46 and in our study, black men reported higher prevalence of CAM use compared to white men (the difference was marginally significant). Using data from the current cohort, Krousel-Wood et al demonstrated that black participants were more likely than their white counterparts to have low adherence to antihypertensive medications when reporting CAM use. 46 It is possible that the difference in the association between CAM use and low adherence between blacks and whites can be explained by race differences in the types of CAM used and whether it is used as a complement or an alternative to antihypertensive medication. This was beyond the scope of the current analysis and should be the focus of future research. Our analysis extends previous findings by demonstrating that the race difference in the association between CAM use and low antihypertensive medication adherence was present only among men and highlights an opportunity for providers to communicate with men about their CAM use and any trade-offs with respect to antihypertensive medication adherence.
Added Value of Sex-Race Subgroup Analysis
Our results among women demonstrate that sexrace stratification can clarify the effect of race on associations between risk factors and low antihypertensive medication adherence identified in sex-stratified analyses. Furthermore, sex-race stratification may uncover risk factors that are not identified in analyses stratified by race or sex alone, as we found in men. Both of these functions enhance our ability to identify those at risk for low medication adherence and develop interventions targeting relevant risk factors for low antihypertensive medication adherence. In addition, sex-race stratification can aid reproducibility of results: inconsistent results in prevalence rates and determinants of low adherence seen across previous studies may be due to differences in the sex-race distribution of participants.
Limitations and Strengths
The findings should be considered in light of the study limitations. The cross-sectional and observational nature of the study does not allow for causal inferences. Although the study included a relatively large sample of elderly black and white participants, the number of black male participants (n = 188) was low compared to other sex-race subgroups, which could limit the statistical power of the study to detect significant associations for this subgroup; future studies including larger sample sizes for subgroup analyses are needed to confirm the findings. Pharmacy refill is an indirect measure of adherence and we cannot confirm that the medications were actually taken correctly by patients; however, prior research has found that pharmacy refill adherence is associated with blood pressure control and outcomes. 47 Further, some of the patients may have filled prescriptions outside of the managed care organization's database and these claims data may not have been included in the analysis. In addition, the inclusion of English-speaking community-dwelling older adults in a managed care organization from one geographic area may not be generalizable to all patients with hypertension. While the factors identified in these analyses can be used as markers for low antihypertensive medication adherence, further research is needed to determine whether or not changes in modifiable risk factors associated with low adherence lead to improved adherence and better blood pressure control.
This study has several strengths, including a diverse sample of black and white participants with respect to socio-demographic characteristics and the presence of cardiovascular risk factors. Antihypertensive medication adherence was assessed using an objective measure of PDC, which has been correlated to blood pressure control and cardiovascular disease outcomes. 47, 48 We were able to link comprehensive participant risk factor survey data to pharmacy refill adherence and medical claims. The restriction of the study sample to older adults in a managed care setting minimizes the confounding effects of health insurance, access to care, and employment status in the older adult population. Finally, because hypertension is a prevalent disease in older adults, the results of this study may be useful in the management of a substantial portion of the elderly, insured population with hypertension. identified across 4 sex-race subgroups of CoSMO participants. This study extends prior research by highlighting sex-race differences not identified when looking at sex or race alone and by providing insights on the effect of race on associations between low adherence and risk factors identified in sex-stratified analysis. It is possible that these differences may underlie inconsistencies in adherence research results among women vs. men. The identification of risk factor differences in sex-race groups may inform future clinical studies and personalized precision healthcare aimed at improving antihypertensive medication adherence and blood pressure control.
